ARTICLE
|
doi:10.20944/preprints202404.0523.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
pharmacovigilance; adverse drug reactions; ChatGPT; artificial intelligence; phase 4 studies; drug safety
Online: 8 April 2024 (11:16:12 CEST)